Regulation of cell growth and metabolism by protein tyrosine phosphorylation involves dephosphorylation via the action of protein tyrosine phosphatases (PTPases). We have characterized the membrane PTPases in rat liver, monitoring their activity by measuring the dephosphorylation of P-Tyr-reduced, carboxyamidomethylated and maleylated lysozyme (P-Tyr-RCML) and P-Tyr-myelin basic protein (P-Tyr-MBP). Separation of membrane PTPases by poly (L-lysine) chromatography yielded three peaks of PTPase, termed I, II and III. PTPases I and II were most active with P-Tyr-RCML, whereas PTPase III showed greater activity with P-Tyr-MBP than with P-Tyr-RCML (ratio of activities 4:1). Separation of membrane proteins by gel-filtration chromatography yielded two peaks of activity. Based on substrate specificity, sensitivity to inhibitors and requirement for thiol-containing compounds, the activity peak with an Mr of -400000 corresponded to PTPase III, whereas that with an Mr of approx. 40000 contained PTPases I and II. All three PTPases dephosphorylated epidermal growth factor receptors and insulin receptors, but only PTPases I and II were active with P-Tyr-asialoglycoprotein receptors. Although none of the above characteristics distinguished between PTPases I and II, only PTPase I reacted in a Western immunoblotting procedure with anti-peptide antibodies directed towards human placental PTPase. We conclude that the membrane fraction from rat liver contains at least three distinct PTPases.
INTRODUCTION
Protein phosphorylation is well established as a posttranslational regulatory mechanism which is involved in the control of numerous and diverse cellular processes. In recent years the phosphorylation of proteins on tyrosine has assumed a role of central importance in the control of cell growth [1, 2] . Although numerous protein tyrosine kinases have been characterized over the last decade, elucidation of the nature and regulation of protein tyrosine phosphatases (PTPases; proteintyrosine-phosphate phosphohydrolase, EC 3.1.3.48) has begun only recently. The purification to homogeneity of a 35000-Mr PTPase from human placenta several years ago by Tonks and colleagues [3, 4] led to the first data on the primary structure of a PTPase, termed lB. Surprisingly, the sequence of this enzyme showed similarity to that of the cytoplasmic domain of the leucocyte cell surface protein CD45 [5] . Shortly thereafter it was demonstrated that CD45 (also called Ly-5, T200 or B220; for a review, see [6] ) is indeed a transmembrane PTPase [7] . Subsequent work has demonstrated at least two distinct classes of PTPases. PTPases analogous to placental PTPase B with an Mr of approx. 50 000 have been cloned from rat brain [8] , human T cells [9] and human placenta [10] . CD45, a leucocyte-specific protein, has been shown to have a relative, called LAR (leucocyte antigen related), which is also a transmembrane protein with PTPase activity in its cytoplasmic domain [11] .
We have recently reported on the characterization of PTPases in rat liver, with emphasis on the effects of experimental diabetes on protein-tyrosine dephosphorylation [12] . Using phosphotyrosyl-reduced, carboxyamidomethylated and maleylated lysozyme (P-Tyr-RCML) and P-Tyr-poly(Glu4,Tyr1) (polyEY) as substrates, our results indicated a single class of PTPases distributed in soluble, membrane (cell surface and endosomal) and cytoskeletal fractions. Soluble PTPase activity could be generated by proteolysis of membranes. PTPase in the particulate subcellular fractions had activity against multiple substrates, including insulin receptors and epidermal growth factor (EGF) receptors. PTPase activities in the subcellular fractions also had similar sensitivities to PTPase inhibitors. Our earlier results were consistent with the presence of a single PTPase in rat liver, in contrast with the molecular cloning data now available indicating multiple PTPases. We have therefore attempted the further characterization and purification of rat liver PTPases.
MATERIALS AND METHODS

Materials
Wheat-germ-lectin-Sepharose 6MB, DEAE-Sepharose CL-6B, Ultrogel AcA 44 and MonoQ (prepacked, f.p.l.c.) were obtained from Pharmacia Fine Chemicals, Piscataway, NJ, U.S.A. Affi-Gel Blue was obtained from Bio-Rad Laboratories, Richmond, CA, U.S.A. Poly(L-lysine)-agarose, heparin-agarose, iminodiacetic acid-agarose and Triton X-100 were obtained from Sigma Chemical Co., St. Louis, MO, U.S.A. [y-32P]ATP was obtained from New England Nuclear Research Products, Boston, MA, U.S.A. Lysozyme was reduced and carboxyamidomethylated as described previously [3] for use as a phosphatase substrate. Myelin basic protein (MBP; from bovine brain), also used as phosphatase substrate, was obtained from Sigma.
Measurement of PTPase activity
PTPase activity was measured as the release of 32P from substrates phosphorylated on tyrosine [13] . Assays were carried ethanol. RCML and MBP were labelled on tyrosine residues using partially purified human placental insulin and EGF receptor tyrosine kinases, as described by Tonks et al. [3] . Phosphorylation of MBP was optimized by freezing and thawing five times before use. Dephosphorylation of both substrates was measured at a final P-Tyr-substrate concentration of 1 ,SM.
Preparation of rat liver membrane and cytoskeletal fractions Unfractionated liver membranes were made from fresh livers by the method of Williams et al. [14] . As described previously [12] , we define membrane proteins as being soluble in 1 % Triton X-100, whereas cytoskeletal proteins are defined as being insoluble in detergent but soluble in 0.6 M-KCI.
Preparation of rat liver extracts for PTPase purification
Sprague-Dawley rats (Charles River Breeding Laboratories Inc., Wilmington, MA, U.S.A.) were killed by decapitation under Nembutal anaesthesia. Livers were removed immediately and placed on ice until homogenization. Pooled livers (55-70 g) were homogenized using a Waring blender with 10 ml of buffer A/g (buffer A = 50 mM-Hepes, 0.25 M-sucrose and 5 mM-EDTA, pH 7.4) containing freshly added 5 mM-benzamidine, 0.002 % phenylmethanesulphonyl fluoride (PMSF), and aprotinin (3 units/ml). The homogenate was centrifuged at 1000 gfor 15 min and the pellet was discarded. The supernatant was brought to 1 % Triton X-100 and stirred for 45 min at 4 'C. Detergentinsoluble protein was removed by centrifugation (14000 g for 30 min) and 2-mercaptoethanol was added to the extract to a concentration of 0.4 % (v/v). Protein determinations were made using the method of Bradford [15] or, for detergent-extracted samples, the bicinchoninic acid method (BCA; Pierce Chemical Co., Rockford, IL, U.S.A.). Protein assays used BSA as a standard.
Production of anti-peptide antibodies
Antibodies against a synthetic peptide (ENLTTQETREIL-HFHYTT) corresponding to residues 161-178 in the human PTPase [16] were produced in rabbits and affinity purified using the immobilized peptide (F. Pinault & D. L. Brautigan, unpublished work).
Western immunoblotting
Proteins separated by PAGE were transferred electrophoretically to nitrocellulose membranes and detected by a Western immunoblotting procedure utilizing 125I-Protein A [17] . Briefly, the nitrocellulose membranes were first incubated in a quench solution, after which they were incubated overnight at room temperature in a solution of anti-peptide antibodies ( Rat liver insulin receptors and EGF receptors were partially purified from membrane preparations using wheat-germ lectin affinity chromatography [12] . For [18] and immunoprecipitated using antibodies against the human receptor bound to Sepharose beads [19] . A time course of dephosphorylation was performed by incubating 110 ,ul of suspended beads with 110 ,ul of PTPase at 37 'C. At various times, 40 1l portions of the mixture were transferred to a tube containing 10 ,ul of 5 mMvanadate. The beads were collected by centrifugation and the bound ASG receptor was eluted by boiling in gel electrophoresis sample buffer. Electrophoresis and autoradiography proceeded as above.
RESULTS
Separation of membrane PTPases by poly(L-lysine)-agarose affinity chromatography
An extract of rat liver membranes containing 58 mg of protein was applied to a 10 ml column of poly(L-lysine)-agarose equilibrated in buffer B (see Fig. 1 legend). After washing with 20 ml of buffer B, PTPases were eluted with a linear gradient from 0 to 1 M-NaCl in the same buffer ( Fig. 1 ). Using P-Tyr-RCML as substrate there were two major and two minor peaks of activity, with most of the activity eluting between 0.2 and 0.5 M-NaCl.
The peak eluting at fractions 35-45 was present in varying amounts in multiple preparations. In contrast, with P-Tyr-MBP as substrate, the fractions up to 0.5 M-NaCl had little activity, 0.6k whereas a broad peak that eluted between 0.5 and 0.8 M-NaCl had higher activity with P-Tyr-MBP than with P-Tyr-RCML. In some preparations (such as that shown in Fig. 1 ) three distinct peaks of activity with P-Tyr-MBP were recovered, whereas in other preparations a single broad peak was obtained. Sensitivity We have previously noted sensitivity of rat liver PTPase activity to polyEY [12] . As with rat liver extracts, PTPase activity measured with P-Tyr-RCML was indeed inhibited by polyEY (Fig. 2b) . Of note is the fact that PTPases I and II were more sensitive to polyEY than was PTPase III. In contrast, with P-Tyr-MBP as substrate (Fig. 2a ) PTPases I and II were activated 4-fold by as little as 2.5 /sM-polyEY. However, PTPase III was not activated but was inhibited by polyEY when P-Tyr-MBP was used as substrate.
Proteins in membrane extracts were also separated by gelfiltration chromatography using an SW-300 pre-packed column (Waters Chromatography Division, Milford, MA, U.S.A.). PTPase activity measured with P-Tyr-RCML as substrate was present in two distinct activity peaks with Mr values of approx. 400000 and 40000 (Fig. 3) . However, the high-Mr PTPase had almost 4-fold higher activity with P-Tyr-MBP (ratio of activity with MBP/RCML for fraction 31 = 3.7). The lower-Mr PTPases displayed only about one-eighth of the activity with P-Tyr-MBP compared with P-Tyr-RCML (MBP/RCML ratio = 0.11 for fraction 53 and 0.15 for fraction 57).
Charactization of the properties of the high-and low-Mr PTPases obtained by gel-filtration f.p.l.c. used P-Tyr-MBP as substrate. The high-Mr PTPase was inhibited by polyEY, whereas the lower-Mr PTPases were activated. Thus we conclude that PTPases I and II correspond to the lower-Mr PTPase obtained by gel-filtration f.p.l.c., whereas PTPase III corresponds to the high-Mr enzyme.
Based on substrate specificity, it seems that PTPases also differ in subcellular localization (Table 1) . Activity measurements made on soluble, membrane and cytoskeletal fractions from five livers showed that the specific activity with P-Tyr-RCML was comparable in membrane and cytokeletal fractions. In contrast, activity with P-Tyr-MBP was nearly 3-fold higher in membrane fractions than in cytoskeletal fractions. In both cases, specific activities in the soluble fractions were low.
PTPase activities in unfractionated membrane extracts, measured with P-Tyr-RCML and P-Tyr-MBP, also differed in their dependence on thiol-containing reducing agents (Fig. 4 We purified PTPases I and II further to better characterize their properties. Yields from membrane preparations were insufficient for our purpose so we began with rat liver homogenates extracted with 1 % Triton X-100 (see the Materials and methods section). The addition of 0.4 % 2-mercaptoethanol to the extract resulted in a significant (6-7-fold) increase in PTPase activity, consistent with the dependence on reducing agents noted above. However, 0.4 % 2-mercaptoethanol did not prevent the loss of activity in the more dilute protein solutions that occurred during the latter stages of purification.
Purification of PTPase, monitored as the dephosphorylation of P-Tyr-RCML, proceeded as follows. The extracted homogenate was adsorbed to an equivalent volume of DEAE-Sepharose CL-6B equilibrated in buffer B and step-eluted with buffer B containing 0.5 M-NaCl. The eluate was precipitated by the addition of (NH4)2SO4 to 70 % satn. The precipitate was centrifuged and resuspended in a minimum volume of buffer B. The sample was dialysed against 10 mM-Hepes (pH 7.25)/25 mmNaCI/0.4 % 2-mercapthoethanol and adsorbed to 90 ml of poly(L-lysine)-agarose equilibrated in buffer B, and washed with 1 column vol. of the same. PTPase activity was eluted with a linear salt gradient from 0 to 0.5 M-NaCl in buffer B. In multiple preparations this generated two separate peaks ofPTPase activity (Fig. 5) , each of which was pooled for further purification. These PTPase activities were eluted at NaCl concentrations similar to those for peaks I and II purified from membrane extracts (see Fig. 1 ), and are therefore also designated as PTPases I and II. The relative activities of PTPases I and 11 with P-Tyr-MBP and P-Tyr-RCML, whether purified from membrane extracts or from whole liver extracts, were similar (results not shown).
Purification of liver extract PTPase I and PTPase II proceeded as follows. PTPase I and PTPase II from poly(L-lysine) chromatography were precipitated by 70 % satn. with (NH4)2SO4, centrifuged and resuspended in 50 mM-Hepes, pH 7.0, in order to eliminate reducing agent before zinc affinity chromatography.
Three and five preparations of PTPase I and PTPase II respectively were pooled and adsorbed to 20 ml of iminodiacetic acid-agarose charged with Zn2+ and equilibrated in 10 Fig. 2 . like PTPase I and PTPase II, PTPase III activity was inhibited by zinc (IC50 approx. 120 ,tM) and bound strongly to Zn2+-iminodiacetate-agarose.
Activity of PTPases with P-Tyr-receptor proteins
We studied the activity of membrane PTPases I, II and III, separated by poly(L-lysine) chromatography (see Fig. 1 ), with P-Tyr-ASG receptors, P-Tyr-insulin receptor and P-Tyr-EGF receptors (Fig. 8) . Insulin receptors and EGF receptors were partially purified from human placenta membranes by detergent solubilization and wheat-germ-lectin chromatography. In the presence of [y-32P]ATP, labelling of the respective receptors was dependent on the addition of hormone. Of the 32P-labelled proteins in these preparations, the insulin receptor ,l-subunit (Mr 95000) and the EGF receptor (Mr 170000) were major components, readily identified by their migration in polyacrylamide gels (Fig. 8) . Both the insulin receptor and EGF receptor were dephosphorylated by PTPase I, II and III when comparable amounts of PTPase activity were added for 15 min at 37 'C. However, the PTPases displayed specificity when P-Tyr-ASG receptor was used as substrate. PTPases I and II dephosphorylated P-Tyr-ASG receptors, whereas PTPase III did not produce appreciable dephosphorylation within 30 min.
DISCUSSION
Based on separation during purification, substrate specificity, sensitivity to inhibitors and differential immunoreactivity, there are three distinct membrane PTPases in rat liver. PTPases I and II partially purified from rat liver extracts could be separated by poly(L-lysine)-agarose affinity chromatography. Their characteristics included the following: Mr approx. 40000 based on gelfiltration chromatography; 6-10-fold greater activity with P-Tyr-RCML than with P-Tyr-MBP; sensitivity to inhibition by polyEY (IC50 approx. 2.5 /tM) with P-Tyr-RCML as substrate, in contrast with activation by 2.5 uM-polyEY with P-Tyr-MBP as substrate. These two PTPase activities were indistinguishable based on sensitivity to inhibitors. Their similar sensitivity to polyEY is in contrast with the placental PTPases purified by Tonks et al. [4] , which could be distinguished on this basis. PTPases I and II behaved similarly during purification using multiple affinity chromatography steps, and both enzymes were reactive with insulin receptors, EGF receptors and ASG receptors. However, PTPase I was reactive with anti-peptide antibodies directed against a sequence in human placental PTPase lB [10] which is conserved (16 out of 18 amino acids) in a homologous rat brain PTPase [8] . Proteins detected with these antibodies did not co-purify with PTPase II activity. The peptide against which the antibodies are directed is in the central portion of PTPase 1B, so it is unlikely that PTPase II is simply a proteolytic product of PTPase I. It is possible that the absence of immunoreactivity in the PTPase II preparation is due to posttranslational modification of PTPase I, but we consider it most likely that these are two distinct proteins.
The third PTPase present in the rat liver membranes, designated PTPase III based on elution during poly-(L-lysine) chromatography, clearly differs from PTPases I and II. PTPase III had an Mr of -400000 based on gel-filtration chromatography and displayed 3-4-fold greater activity with P-Tyr-MBP than with P-Tyr-RCML. A number of results show that the catalytic domain of PTPase III is different from that of PTPases I and II. Using P-Tyr-RCML as substrate, PTPase III was less sensitive to polyEY inhibition. Using P-Tyr-MBP as substrate, PTPase III was not activated by polyEY. PTPase activity with P-Tyr-MBP was stable in the presence of low concentrations of thiol-containing compounds. Finally, the subcellular localization of PTPase III seemed to differ from that of PTPases I and II, based on specific activities of membrane and cytoskeletal fractions with P-Tyr-MBP versus P-Tyr-RCML.
Our studies do not establish the identity of PTPase III, which is a high-Mr membrane PTPase. It seems reasonable to speculate that this enzyme may be related to the transmembrane PTPase LAR [11] . Indeed, a preliminary report describes the detection of mRNA in rat liver using the cDNA for LAR [20] . In addition, PTPase III and CD45 enzyme activities share at least one feature, i.e. high activity with P-Tyr-MBP [21] .
Most ofour experiments utilized artificial substrates to monitor and characterize the various PTPases. However, all three rat liver PTPases have activity with at least two physiological substrates, P-Tyr-insulin receptor fl-subunit and P-Tyr-EGF receptor.
Interestingly, only PTPases I and II were active with P-Tyr-ASG receptor. This receptor, unlike the EGF and insulin receptors, undergoes constitutive internalization via coated pits followed by recycling to the plasma membrane. The significance of the selective activity of multiple PTPases with physiological substrates is unknown at this time. The ability of a PTPase to dephosphorylate intrinsic membrane receptors in solution does not ensure a similar role in intact membranes and cells. None- theless, our studies raise the possibility of complex regulation of receptor dephosphorylation by independently regulated PTPases.
